William A Zammarrelli1, Anoushka M Afonso2, Vance Broach3, Yukio Sonoda3, Oliver Zivanovic3, Jennifer J Mueller3, Mario M Leitao3, Amelia Chan4, Nadeem R Abu-Rustum5. 1. Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. 2. Department of Anesthesiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. 3. Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Obstetrics and Gynecology, Weill Cornell Medical College, New York, NY, USA. 4. Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. 5. Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Obstetrics and Gynecology, Weill Cornell Medical College, New York, NY, USA. Electronic address: Abu-rusn@mskcc.org.
Abstract
OBJECTIVE: To describe the incidence of adverse reactions to indocyanine green (ICG) administered during sentinel lymph node (SLN) biopsy for endometrial cancer, and to propose an ICG management algorithm for these patients. METHODS: All patients who underwent surgery for endometrial cancer with SLN biopsy using ICG from 1/2017 to 8/2020 were identified using a single-institution prospective database. Surgical adverse events (SAEs) related to the procedure were identified. A review of the literature was performed. RESULTS: In all, 1414 patients met inclusion criteria and were evaluated. Sixty-seven (4.7%) patients had a history of either an iodine or contrast allergy. No patients had a history of documented ICG allergy. Among patients with an iodine or contrast allergy, 65 (97%) received a corticosteroid with or without diphenhydramine prior to ICG administration. One hundred five patients (7.4%) experienced 116 SAEs. Among these patients, 3 experienced potentially allergic SAEs possibly related to ICG administration. After thorough chart review, however, the likelihood these SAEs were due to ICG appeared low. No patients experienced an anaphylactic response after ICG admission. CONCLUSION: There were no anaphylactic reactions to ICG intracervical administration during 1414 consecutive SLN biopsies, including in patients with a documented iodine or contrast allergy. Intracervical injection of ICG is safe, and premedication using corticosteroids with or without diphenhydramine prior to SLN biopsy is a reasonable strategy in patients with iodinated contrast allergy.
OBJECTIVE: To describe the incidence of adverse reactions to indocyanine green (ICG) administered during sentinel lymph node (SLN) biopsy for endometrial cancer, and to propose an ICG management algorithm for these patients. METHODS: All patients who underwent surgery for endometrial cancer with SLN biopsy using ICG from 1/2017 to 8/2020 were identified using a single-institution prospective database. Surgical adverse events (SAEs) related to the procedure were identified. A review of the literature was performed. RESULTS: In all, 1414 patients met inclusion criteria and were evaluated. Sixty-seven (4.7%) patients had a history of either an iodine or contrast allergy. No patients had a history of documented ICG allergy. Among patients with an iodine or contrast allergy, 65 (97%) received a corticosteroid with or without diphenhydramine prior to ICG administration. One hundred five patients (7.4%) experienced 116 SAEs. Among these patients, 3 experienced potentially allergic SAEs possibly related to ICG administration. After thorough chart review, however, the likelihood these SAEs were due to ICG appeared low. No patients experienced an anaphylactic response after ICG admission. CONCLUSION: There were no anaphylactic reactions to ICG intracervical administration during 1414 consecutive SLN biopsies, including in patients with a documented iodine or contrast allergy. Intracervical injection of ICG is safe, and premedication using corticosteroids with or without diphenhydramine prior to SLN biopsy is a reasonable strategy in patients with iodinated contrast allergy.
Authors: Floor J Backes; David Cohen; Ritu Salani; David E Cohn; David M O'Malley; Emily Fanning; Adrian A Suarez; Jeffrey M Fowler Journal: Gynecol Oncol Date: 2019-04-04 Impact factor: 5.482
Authors: Elizabeth L Jewell; Juan Juan Huang; Nadeem R Abu-Rustum; Ginger J Gardner; Carol L Brown; Yukio Sonoda; Richard R Barakat; Douglas A Levine; Mario M Leitao Journal: Gynecol Oncol Date: 2014-02-28 Impact factor: 5.482
Authors: Leslie L Montgomery; Alisa C Thorne; Kimberly J Van Zee; Jane Fey; Alexandra S Heerdt; Mary Gemignani; Elisa Port; Jeanne Petrek; Hiram S Cody; Patrick I Borgen Journal: Anesth Analg Date: 2002-08 Impact factor: 5.108
Authors: William A Zammarrelli; Michelle Greenman; Eric Rios-Doria; Katie Miller; Vance Broach; Jennifer J Mueller; Emeline Aviki; Kaled M Alektiar; Robert A Soslow; Lora H Ellenson; Vicky Makker; Nadeem R Abu-Rustum; Mario M Leitao Journal: Gynecol Oncol Date: 2022-02-26 Impact factor: 5.304
Authors: Beryl L Manning-Geist; Renee A Cowan; Brooke Schlappe; Kenya Braxton; Yukio Sonoda; Kara Long Roche; Mario M Leitao; Dennis S Chi; Oliver Zivanovic; Nadeem R Abu-Rustum; Jennifer J Mueller Journal: Gynecol Oncol Rep Date: 2022-02-03